Larvol Omni

Discover the next generation of KOL tracking with Larvol Omni
Request A Demo

Stay ahead with comprehensive updates on KOL activity.
Omni includes publications, clinical trial involvement, social media, and upcoming event attendance.

Keep Up-to-Date


Clyde W. Yancy, MD

Northwestern University Feinberg School of Medicine, Chicago, IL, US

llllllllll Why COVID-19 is so dangerous for the heart

(WGN9 TV), 03/29/2020

‘”The risk for getting the infection might not increase but if you have the infection, and underlying heart disease, the consequence is not only more serious, they can be dire,’ he said….’If we can practice these important public health measures, we really can help flatten the curve,’ Yancy said.”
Media Quote



llllllllll New therapy module for severe heart failure

(Kardiologie), 03/30/2020

Sometimes I see adequately diverse representation on the podium at cardiology meetings I attend in some sessions, but often I leave feeling there is not enough. But here’s the great thing: Our next ACC president is a woman, Athena Poppas, MD, who will assume the presidency in March 2020….This discussion instigated by the Lancet group merits further exploration.
Media Post

[POSTPONED] Nutrition Science from Populations to Plates: What Every Clinician Needs to Know

05/03/2020, Chicago, IL, USA

“This event has been postponed. “Identify the magnitude of health benefit possible from dietary interventions, Demonstrate how to respond to common nutrition questions from patients, Demonstrate simple food selection and cooking tips to be shared with patients to promote healthy eating…”


[POSTPONED] 9th Annual Chicago Cardiovascular Update

07/23/2020 – 07/25/2020, Chicago, IL, USA

This event has been postponed. “Thursday, July 23, 2020, 7:00 AM – Saturday, July 25, 2020, 6:00 PM; Outline strategies for the treatment of hypertension, hyperlipidemia, arteriosclerotic heart disease and diabetes, including the use of newer pharmacological agents and lifestyle therapies, Identify candidates for Cardiac Resynchronization and wearable versus implantable cardioverter-defibrillator therapies…Apply knowledge gained in the conference through clinical case review and MOC cases.”
Northwestern Medicine

EPI-LIFESTYLE 2020 Epidemiology and Prevention | Lifestyle and Cardiometabolic Health

03/03/2020 – 03/06/2020, Phoenix, AZ, USA
2 Abstracts

ACC 2020 The American College of Cardiology’s 69th Annual Scientific Session & Expo (Virtual Meeting)

3/28/2020 – 03/30/2020, Chicago, IL, USA
18 Abstracts

ADA 2020 American Diabetes Association’s 80th Scientific Sessions (Virtual Meeting)

06/12/2020 – 09/16/2020, Chicago, IL, USA
1 Abstract

PARAGON-HF Clinical Trial Eligibility in a Population of Patients Hospitalized with Heart Failure


Representatives of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF


A new and potentially important phenotype of heart failure emerges

Clyde Yancy, MD, @NMHheartdoc

“A new and potentially important phenotype of heart failure emerges; an evolving database suggests that HF with midrange EF is associated with better outcomes. No yet identified therapies. Continue GDMT. Need to discover pathways of recovery.”

Leading the way for a bold future

Clyde Yancy, MD, @NMHheartdoc

“Leading the way for a bold future; Masters level training in Artificial Intelligence- new language, new tool and new opportunities. Looking forward to seeing the best of the best apply and work with @NMCardioVasc @JamesDThomasMD1 @NorthwesternMed @NUFeinbergMed”

IMPROVE-HF: IMPROVE HF: Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting



AC6 Gene Transfer for CHF



Omni Content

Omni makes it even easier to access targeted news, events, clinical trials, tweets, and more for the KOLs critical to your pipeline. Access Omni on desktop or mobile so that you never miss an important development or engagement.

Key Features

Sunshine Data

KOL Analytics

Bookmark Content

Push Notifications

Take Notes

Contact Info

Why Track KOLs?


We know how valuable the opinions of KOLs are. Monitoring KOL activity allows for a better understanding of how the physician community receives your messages and lets you identify concerns and education opportunities. Never miss an opportunity to engage.


Tracking KOLs ensures that your products are included in relevant discussions. Knowing where a KOL is going to be – which conferences, symposiums, and CME events they’ll be attending or presenting at – allows for crucial opportunities to engage with a KOL and the other physicians who follow them. Our customers explain how valuable it is to see that a KOL is publicly discussing mechanisms of action that they’re working with and creates an opportunity to reach out and establish a key relationship.


Mapping is the process of identifying thought leaders / KOLs that are influential in your area and their relationships. Tracking comes after mapping and involves monitoring the ongoing activity (publications, opinions, and events) of specific KOLs to better understand the evolution of their positioning. Tracking also ensures that you are up-to-date with the perspectives of your KOLs and that you can identify opportunities to engage with them.

Our Complete KOL Monitoring Solution Includes


Publications, trial updates, news, media mentions – any news item that isn’t an event or a tweet.


Calendar listing of upcoming conferences, symposiums, lectures, CME and other events that a KOL is attending or speaking at.

Social Media

Twitter provides a direct line to your key influencers’ reactions. You can find tweets authored by the KOL as well as mentions of the KOL by others.

Clinical Trials

Updates on the latest clinical trials associated with your KOLs, covering both and EudraCT. Includes changes such as enrollment status, new data, discontinuations and more.

Request A Demo

Enter your information to be contacted by our sales team about Larvol Omni,

to schedule a demo, or subscribe.

Yes, I would like to subscribe to updates from Larvol